ACE inhibitors reduce the level of oxidative stress (H2O2, malondialdehyde (MDA), and reactive oxygen species (ROS) formation) and increase anti-oxidative activity in rats with hyperglycemia, diabetes, hepatic fibrosis, and hypertension [4,5,6]. The gene discussed is ACE; the disease is Hypertension.